Teleflex
Purpose Driven Innovation in Interventions

It all started in 1943 when an engineering-focused operating company, Teleflex, was born, with a multi-strand, flexible helical cable and gear being their only product. Over the years, Teleflex evolved to a diversified industrial company, finally transitioning to a pure-play medical device company. With a diverse portfolio, Teleflex is a global provider of medical technologies with solutions that cater to a range of medical fields spanning vascular and interventional access, surgical, anesthesia, urology, emergency medicine, and respiratory care. Their products equip interventional cardiologists with the required tools to manage routine and complex clinical cases, thereby resulting in improved patient outcomes. Applying purpose-driven innovation, Teleflex continuously identifies existing clinical challenges for the benefit of patients and healthcare providers alike.

One of the most popular products of Teleflex is the GuideLiner Catheter, built by another innovative medical device company, Vascular Solutions, a part of Teleflex. The GuideLiner Catheter radically .

altered the concept of guide extension, bringing forth new possibilities in interventional cardiology. Apart from its unique proprietary half-pipe technology, the GuideLiner V3’s coil-reinforced extension is specially adjusted to allow dependable deep-seating for transporting interventional devices to distal locations. Inside the catheter tool is a half-pipe channel that lessens device-collar interaction by directing and aligning devices through the collar transition, making way for easier device entry and seamless delivery. Since its launch, GuideLiner Catheters have established themselves as essential tools for interventionalists in tackling complicated anatomies. Currently, in its third iteration, the GuideLiner V3 Catheter’s innovation and .

performance surpasses expectations, clearly demonstrated by more than half a million of these catheters being adopted in cath labs worldwide.

GuideLiner Catheters have established themselves as essential tools for interventionalists in tackling complicated anatomies

Besides the GuideLiner V3 Catheter, cardiologists worldwide rely on the standard and certified clinical effectiveness of a number of Teleflex’s solutions, such as the R350 Guidewire Twin-Pass Torque Dual Access Catheter and Turnpike Catheter. Another noteworthy tool built on the well-known GuideLiner Catheter platform is the TrapLiner Catheter, a unique device specially created to improve efficiency by reducing the complexity in interventional procedures. The TrapLiner is an amalgamation of the characteristics of a guide extension catheter and state-of-the-art guidewire trapping features in a single device. The tool mainly comes into use during clinical cases where over-the-wire microcatheters are required to cross calcified lesions, navigate bifurcations, or cross tortuous anatomy. During such procedures, the TrapLiner provides additional backup support and deep-seating for the guide catheter. Simultaneously, it also enables the user to hold the guidewire in position when exchanging the microcatheter.

In the face of the ever-changing dynamics of COVID-19, Teleflex devoted itself to guaranteeing the effectiveness of their global operations to maintain the supply of their medical devices. At the same time, the company practiced optimal health and safety regulations to ensure the well-being of its employees. Understanding that their products are one of the critical elements in the delivery of healthcare, Teleflex has a dedicated global COVID-19 task force with representatives from critical business functions to steer them swiftly in response to the situation. In the midst of this pandemic, the company’s aim to improve the health and quality of human lives got a new meaning. Even on the business end, Teleflex is leaving no stone unturned in their efforts to mitigate any possible risks to their product supplies to continuously satisfy their customers, patients, and health care professionals.